SCHEMBL6929485

SCHEMBL6929485

CN(C[C]=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
GRM5 P41594 1/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HTT P42858 1/20 0.43
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
PPARG P37231 1/20 0.38
TAAR1 Q96RJ0 2/20 0.38
TSHR P16473 2/20 0.38
ALDH1A1 P00352 1/20 0.38
GLA P06280 1/20 0.38
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
CYP3A4 P08684 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
PYCR1 P32322 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5982497 0.77 MAOB (0.53) CA12CA2CA9GRM5TSHR
SCHEMBL8331122 0.77 GRM5 (0.53) CA12CA2CA9GRM5MEN1
SCHEMBL304704 0.77 MAOB (0.47) CA12CA2CA9GRM5MEN1
SCHEMBL10696444 0.76 MTNR1A (0.38) MEN1KMT2AHTTCRHBPCRHR2
SCHEMBL22485593 0.76 GRM5 (0.51) CA12CA2CA9GRM5MEN1
SCHEMBL10697193 0.75 CA12 (0.42) CA12CA2CA9MEN1KMT2A
SCHEMBL9214815 0.74 TSHR (0.53) MEN1KMT2ATAAR1TSHRALDH1A1
SCHEMBL10764283 0.74 CA12 (0.41) CA12CA2CA9MEN1KMT2A
SCHEMBL3486864 0.73 NPSR1 (0.39) MEN1KMT2AHTTTSHRALDH1A1
SCHEMBL6830597 0.72 GRM5 (0.45) CA12CA2CA9GRM5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0833839-B1 PEPTIDYL HETEROCYCLES USEFUL IN THE TREATMENT OF THROMBIN RELATED DISORDERS ORTHO PHARMA CORP (US) 2003-01-08 EP claimed
CN-105693682-A Zhaoqing hesperetin hydrazone compound and application thereof 李充璧 2016-06-22 CN disclosed
EP-1361212-A1 Peptide derivatives as antithrombotic agents AstraZeneca AB (SE) 2003-11-12 EP disclosed
EP-1110968-B1 Intermediate for the preparation of Thrombininhibitors as anticoagulant agents LILLY CO ELI (US) 2003-10-01 EP disclosed
EP-0672658-B1 Antithrombotic agents ASTRAZENECA AB (SE) 2003-09-17 EP disclosed
US-6552038-B1 For use as thrombin inhibitors, coagulation inhibitors and agents for therapy of thromboembolic disorders ELI LILLY AND COMPANY 2003-04-22 US disclosed
US-6534650-B2 Thrombin inhibitors ELI LILLY AND COMPANY 2003-03-18 US disclosed
EP-1135023-A4 AMINOBENZISOXAZOLE COMPOUNDS AND LIBRARIES THEREOF LILLY CO ELI (US) 2003-03-05 EP disclosed
EP-0816376-B1 Trombin inhibitors as anticoagulant agents LILLY CO ELI (US) 2002-11-06 EP disclosed
EP-0622361-B1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO (JP) 2001-10-04 EP disclosed
WO-1995023608-A1 ANTITHROMBOTIC AGENTS ELI LILLY AND COMPANY (US) 1995-09-08 WO disclosed
US-5430023-A Tripeptide antithrombotic agents ELI LILLY AND COMPANY (US) 1995-07-04 US disclosed
EP-0622361-A1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-11-02 EP disclosed
EP-0596406-A1 Imidazo (1,2-a) Pyridines as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-05-11 EP disclosed
US-5250660-A Peptide purification process ELI LILLY AND COMPANY (US) 1993-10-05 US disclosed
EP-0252482-A2 7-Acyloxy-6-aminoacyloxypolyoxylabdanes, process for their preparation and their use as medicine HOECHST AKTIENGESELLSCHAFT (DE) 1988-01-13 EP disclosed
US-4675397-A MICROBIOCIDES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1987-06-23 US disclosed
US-4665067-A BACTERICIDES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1987-05-12 US disclosed
EP-0217372-A2 Polyoxygenated labdane derivatives, process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1987-04-08 EP disclosed
EP-0053387-A1 Method of preparing 1-sulfo-2-oxoazetidine derivatives and intermediates therefor Takeda Chemical Industries, Ltd. (JP) 1982-06-09 EP disclosed